Related references
Note: Only part of the references are listed.Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors
Shih Wee Seow et al.
CANCER SCIENCE (2010)
Control of death receptor ligand activity by posttranslational modifications
R. Weinlich et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer
Jean-Charles Soria et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
“Combination-oriented molecular-targeting prevention” of cancer: a model involving the combination of TRAIL and a DR5 inducer
Tatsushi Yoshida et al.
Environmental Health and Preventive Medicine (2010)
Curcumin Potentiates the Antitumor Effects of Bacillus Calmette-Guerin against Bladder Cancer through the Downregulation of NF-kB and Upregulation of TRAIL Receptors (Publication with Expression of Concern. See vol. 78, pg. 5182, 2018)
Ashish M. Kamat et al.
CANCER RESEARCH (2009)
Inhibition of urinary bladder carcinogenesis by broccoli sprouts
Rex Munday et al.
CANCER RESEARCH (2008)
Baicalein Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Hiroya Taniguchi et al.
CANCER RESEARCH (2008)
History of bacillus Calmette-Guerin and bladder cancer: An immunotherapy success story
Harry W. Herr et al.
JOURNAL OF UROLOGY (2008)
Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface
Tomoyo Kawakubo et al.
CANCER RESEARCH (2007)
Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha
Kesavan Esuvaranathan et al.
CANCER (2007)
Gene therapy with TRAIL against renal cell carcinoma
Hiroki Matsubara et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells
Taka-Aki Matsui et al.
CARCINOGENESIS (2006)
Tumour microenvironment - Opinion - Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
CM Overall et al.
NATURE REVIEWS CANCER (2006)
Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy
Izumi Shimbo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L
TJ Kemp et al.
BLOOD (2005)
Promoting apoptosis as a strategy for cancer drug discovery
SW Fesik
NATURE REVIEWS CANCER (2005)
Mycobacterium bovis bacille Calmette Guerin infection of human neutrophils induces CXCL8 secretion by MyD88-dependent TLR2 and TLR4 activation
G Godaly et al.
CELLULAR MICROBIOLOGY (2005)
Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells
Toshiyuki Nomura et al.
JOURNAL OF MEDICAL INVESTIGATION (2005)
Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase
CA Owen et al.
JOURNAL OF IMMUNOLOGY (2004)
Tumor necrosis factor-related apoptosis-inducing ligand: A novel mechanism for Bacillus Calmette-Guerin-induced antitumor activity
AT Ludwig et al.
CANCER RESEARCH (2004)
Neutrophil granules and secretory vesicles in inflammation
M Faurschou et al.
MICROBES AND INFECTION (2003)
TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG
KA Heldwein et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase
J Ninomiya-Tsuji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI
H Seki et al.
PEDIATRICS INTERNATIONAL (2003)
Strategies for MMP inhibition in cancer:: Innovations for the post-trial era
CM Overall et al.
NATURE REVIEWS CANCER (2002)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2
T Takahashi et al.
JOURNAL OF UROLOGY (2001)
Roles of Toll-like receptors in innate immune responses
K Takeda et al.
GENES TO CELLS (2001)
Toll-like receptors: critical proteins linking innate and acquired immunity
S Akira et al.
NATURE IMMUNOLOGY (2001)
Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3
GA McQuibban et al.
SCIENCE (2000)
Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats
T Okamoto et al.
JOURNAL OF GASTROENTEROLOGY (2000)
Share Paper
